Cabaron, Khylee U.

HRN: 08-47-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2025
CO-AMOXICLAV 625MG (TAB)
10/25/2025
11/01/2025
PO
1 Tab
Q 12
T/C Tonsillitis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: